Elimination of onchocerciasis from Africa: Possible?

Trends in Parasitology

Volumn 28, Issue 1, 2012, Pages 16-22

  Mackenzie, Charles D ^a   Homeida, Mamoun M ^b   Hopkins, Adrian D ^c   Lawrence, Joni C ^c  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MEDICAL SCIENCES AND TECHNOLOGY   (Sudan)

^c Mectizan Donation Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; DOXYCYCLINE; IVERMECTIN;

AFRICA; ASCARIASIS; BLOOD EXAMINATION; BRAIN DISEASE; CHEMOPROPHYLAXIS; DIAGNOSTIC TEST; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; DRUG INDUSTRY; ECTOPARASITOSIS; EMBOLIC ENCEPHALOPATHY; ENDEMIC DISEASE; ERADICATION THERAPY; FUNDING; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; IMMUNOASSAY; INFECTION CONTROL; MEDICAL RESEARCH; MICROORGANISM DETECTION; NON PROFIT ORGANIZATION; ONCHOCERCIASIS; POLITICS; PREVALENCE; PUBLIC-PRIVATE PARTNERSHIP; REVIEW; RISK REDUCTION; STRONGYLOIDIASIS; VECTOR CONTROL; VIRUS LOAD;

EID: 84455169524     PISSN: 14714922     EISSN: 14715007     Source Type: Journal    
DOI: 10.1016/j.pt.2011.10.003     Document Type: Review

References (25)

1. Lindblade K.A., et al. Elimination of Onchocerca volvulus transmission in the Santa Rosa Focus of Guatemala. Am. J. Trop. Med. Hyg. 2007, 77:334-341.
2. Dadzie Y., et al. Final report of the conference on the eradicability of Onchocerciasis. Filaria J. 2003, 2:2.
3. Benton B., et al. Partnership and promise: evolution of the African river-blindness campaigns. Ann. Trop. Med. Parasitol. 2002, 96(Suppl. 1):S5-S14.
4. Pacqué M., et al. Improvement in severe onchocercal skin disease after a single dose of ivermectin. Am. J. Med. 1991, 90:590-594.
5. Murdoch M.E., et al. A clinical classification and grading system of the cutaneous changes in onchocerciasis. Br. J. Dermatol. 1993, 129:260-269.
6. Diawara L., et al. Feasibility of Onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal. PLoS Negl. Trop. Dis. 2009, 3:e497.
7. Higazi T., et al. Short report: Polymerase chain reaction pool screening used to compare prevalence of infective black flies in two onchocerciasis foci in Northern Sudan. Am. J. Trop. Med. Hyg. 2011, 84:753-756.
8. Sékétéli A., et al. The achievements and challenges of the African Programme for Onchocerciasis Control (APOC). Ann. Trop. Med. Parasitol. 2004, 96:15-28.
9. Tielsch J., et al. Impact of ivermectin on illness and disability associated with onchocerciasis. Trop. Med. Int. Health 2004, 9:A45-A56.
10. Vieira J.C., et al. Impact of long-term treatment of onchocerciasis with ivermectin in Ecuador: potential for elimination of infection. BMC Med. 2007, 5:9.
11. Cupp E.W. Treatment of Onchocerciasis with ivermectin in Central America. Parasitol. Today 1992, 8:212-214.
12. Cupp E., et al. Elimination of human onchocerciasis: history of progress and current feasibility using ivermectin (Mectizan) monotherapy. Acta Trop. 2011, 120:S100-S108.
13. Traore S., et al. The elimination of the onchocerciasis vector from the island of Bioko as a result of larviciding by the WHO African Programme for Onchocerciasis Control. Acta Trop. 2009, 111:211-218.
14. Taylor M.J., et al. Onchocerciasis control: vision for the future from a Ghanian perspective. Parasit. Vectors 2009, 2:7.
15. Hoerauf A., et al. Doxycycline in the treatment of human onchocerciasis: kinetics of Wolbachia endobacteria reduction and of inhibition of embryogenesis in female Onchocerca worms. Microbes Infect. 2003, 5:261-273.
16. Zoure H.G., et al. The geographic distribution of Loa loa in Africa: results of large-scale implementation of the Rapid Assessment Procedure for Loiasis (RAPLOA). PLoS Negl. Trop. Dis. 2011, 5:e1210.
17. ®) on the prevalence and morbidity of onchocerciasis in the village of Gami in the Central African Republic. Ann. Trop. Med. Parasitol. 2002, 96:297-307.
18. Ghalib H.W., et al. Severe onchocercal dermatitis in the Ethiopian border region of Sudan. Ann. Trop. Med. Parasitol. 1987, 81:405-419.
19. Lipner E.M., et al. Field applicability of a rapid-format anti-ov-16 antibody test for the assessment of onchocerciasis control measures in regions of endemicity. J. Infect. Dis. 2006, 194:216-221.
20. Burbelo P.D., et al. A four-antigen mixture for rapid assessment of Onchocerca volvulus infection. PLoS Negl. Trop. Dis. 2009, 3:e438.
21. Mackenzie C.D., et al. Flubendazole: a candidate macrofilaricide for lymphatic filariasis and onchocerciasis field programs. Exp. Rev. Anti Infect. Ther. 2011, 9:497-501.
22. Al-Qubati Y. The first use of ivermectin for the treatment of onchocerciasis in Yemen. Trans. R. Soc. Trop. Med. Hyg. 1994, 88:343.
23. Winnen M., et al. Can ivermectin mass treatments eliminate onchocerciasis in Africa?. Bull. WHO 2002, 80:384-390.
24. Jacobi C.A., et al. Individual exposure to Simulium bites and intensity of Onchocerca volvulus infection. Parasites Vector 2010, 3:53-59.
25. Onchocerciasis: elimination is feasible. Wkly. Epidemiol. Rec. 2009, 84:382-383.